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Introduction
Myocarditis usually presents with spontaneous recovery.
However, it can occasionally lead to sudden death in 10%
or may progress to dilated cardiomyopathy in up to 9% of
cases. The diagnosis is difficult to establish clinically.
Purpose
We applied cardiovascular magnetic resonance (CMR) to
detect myocardial inflammation and we compared the
CMR results with myocardial histology and polymerase
chain reaction (PCR) findings.
Methods
Seventeen patients were prospectively studied, in whom
suspicion of myocarditis had been raised. Endomyocar-
dial biopsy was performed in all of them and submitted
to histopathologic analysis. Real time PCR evaluation of
myocardial speciments was also performed. CMR evalua-
tion of myocardial inflammation was performed using
T2-weighted (T2-W), T1-weighted (T1-W) before and after
contrast media injection, and late enhanced images.
Results
All patients had abnormal CMR and PCR findings. Histol-
ogy showed presence of myocarditis in 8/17 patients
(47%) and PCR of myocardial speciments revealed
Chlamydia trachomatis in 15/17 (88%). Coxsackie B3,
B6, Parvo B19 and Herpes 1–2 were identified in 6, 5 and
4/17 patients respectively. In 10/17 patients (58.8%) a
coexistence of Chlamydia with Coxsackie B3, B6, Parvo
B19 and Herpes 1–2 was revealed. Presence of oedema
was documented in 6/17 patients (35.2%) using T2W.
The relative myocardial enhancement from T1-W was
increased at 10 ± 3 (normal values 2.3 ± 0.3) in 17/17
cases. Areas of late enhancement (LE), with subepicardial
distribution, were located in basal posterolateral or infe-
rior wall in 11/17 (64.7%) cases. Left ventricular ejection
fraction was reduced only in 20% of cases.
Conclusion
Chlamydia induced myocardial inflammation is a com-
mon finding in patients with clinical diagnosis of myocar-
ditis and often coexists with different viruses. Abnormal
CMR findings were in agreement with all myocardial PCR
specimens and 47% of histology findings. CMR evalua-
tion may facilitate the selection of patients for myocardial
biopsy.
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